Comparative characteristics of inducible NO synthase inhibitor and nitric oxide donor in endothelial dysfunction correction caused by osteoarthrosis under experimental conditions
Keywords
osteoarthritis, experimental model, endothelial dysfunction, Von Willebrand factor, endothelial NO synthase, aminoguanidine, L-arginine.Abstract
Study have been carried out on white Wistar line rats (age – 3 months, weight –
180-220 g). According to the tasks the animals were divided into 7 groups. 1st group is intact
(n = 20). 2nd group is rats, which were modeled osteoarthritis without further correction and were withdrawn from the experiment in the first stage (7th day) (n=40). 3rd group is rats, which were modeled osteoarthritis without further correction and removed from the experiment in the second stage (21st day) (n=40). 4th group is rats, in which experimental osteoarthritis was corrected with nonsteroidal anti-inflammatory drugs (NSAIDs) (Diclofenac) and aminoguanidine and removed from the experiment in the first stage (7th day) (n=20). 5th group is rats, in which experimental osteoarthritis was corrected with NSAIDs (Diclofenac) and aminoguanidine and withdrawn from the experiment in the second stage (21st day) (n=20). 6th group is rats, where experimental osteoarthritis was corrected using NSAIDs and a 7% L-arginine solution and withdrawn from the experiment in the first stage (7th day) (n=20). 7th group is rats, in which experimental osteoarthritis was corrected with NSAIDs and 7% L-arginine solution and withdrawn from the experiment in the second stage (21st day) (n=20)
Animals were withdrawn from the experiment for the 7th day and the 21st day after the simulation of the pathological condition. NSAIDs (Diclofenac), aminoguanidine and L-arginine were administered from the beginning of the study.
We have obtained the following results:
The increase in the content of von Willebrand factor (VWF) in the animals blood proves that endothelial dysfunction is an important part of experimental osteoarthritis pathogenesis. It’s revealed the tendency which directed on normalization of the endothelial dysfunction investigated marker at correction by aminoguadine as a part of complex therapy. L-arginine involvement in the complex correction in experimental osteoarthritis more pronouncedly normalized the VWF level, which indicates the endothelial function normalization. The use of nitric oxide donor is more effective in comparison with the inhibition of inducible NO synthase also in the endothelial nitric oxide synthase activity analysis.
References
Tkachuk PV, Strafun SS, Savos'ko SI, Makarenko OM. Strukturnye narushenija kolennogo sustava pri modelirovanii osteoartroza. Travma. 2019;20(1):73-78.
Alekseeva LI, Zajceva EM. Perspektivnye napravlenija terapii osteoartroza. Nauchno-prakticheskaja revmatologija. 2014;52(3):247–250.
Anikin SG, Alekseeva LI. Hondroitina sul'fat: mehanizmy dejstvija, jeffektivnost' i bezopasnost' pri terapii osteoartroza. Sovpemennaja revmatologija. 2012;3:78-82.
Klinicheskie rekomendacii. Revmatologija. Pod red. akad. RAMN E.L. Nasonova. M.: GJeOTAR-Media; 2010.326.
Titov VN. Anatomicheskie i funkcional'nye osnovy jendotelijzavisimoj vazodilatacii, oksid azota i jendotelin. Rossijskij kardiologicheskij zhurnal. 2008;1 (69):71-85.
Lupinskaja JeA. Jendotelij sosudov – osnovnoj reguljator mestnogo krovotoka. Vestnik KRSU. 2003;7:68-73.
Novikova DS, Popova TV, Nasonov EL. Profilaktika serdechno-sosudistyh zabolevanij pri revmatoidnom artrite. Terapevticheskij arhiv. 2009;5:88-96.
Trunov AN, Slavjanskaja TA, Mihajlova TV. Znachenija immunobiohimicheskih pokazatelej v syvorotke krovi i sinovial'noj zhidkosti pri osteoartroze. Allergologija i immunologija. 2002;3(3):434-436.
Parhomenko AN, Lutaj JaM, Irkin OI, Kozhuhov SN, Skarzhevskij AA, Dosenko VE, Mojbenko AA. Kliniko-prognosticheskoe znachenie polimorfizma gena jendotelial'noj no-sintetazy u bol'nyh s ostrymi koronarnymi sindromami. Medicina neotlozhnyh sostojanij. 2014;3(58):45-53.
Koval'ova OM, Demidenko GV, Gorbach TV. Diagnostika jendotelial'noj funkcii - ocenka vazoaktivnogo pula oksida azota. Mіnіsterstvo ohoroni zdorov'ja Ukraїni. Ukraїns'kij centr naukovoї medichnoї іnformacії ta patentno-lіcenzіjnoї roboti. Metodichnі rekomendacії. Kiїv, vidavnictvo SPD FO Tarasenko VP. 2007:16.
Medvedeva NA, D'jakonov KB, Postnikov AB, Bonarcev AP, Slavuckaja AV. Snizhenie oksid azota (NO)-cGMF-zavisimoj rasshiritel'noj reakcii sosudov malogo kruga krovoobrashhenija pri disfunkcii jendotelija. Rossijskij fiziologicheskij zhurnal. 2005;2:132-140.
Vvedenskij BP, Tynynyka LN, Kovalev GA, Sandomirskij BP. Soderzhanie konechnogo produkta oksida azota v hrjashhe i syvorotke krovi krys pri nizkotemperaturnom modelirovanii destruktivno- distroficheskogo processa v kolennom sustave. Problemy kriobiologi. 2011;21(4):421-428.
Malaja LT, Korzh AN, Balkovaja LB. Zndotelial'naja disfunkcija pri patologii serdechno-sosudistoj sistemi. - H. : Torsing, 2000. - 432 s.
Mazaev AA, Najmushin JaA, Haspekova SG. Faktor Villebranda i rastvorim'іj R-selektin u bol'n'їh s ostr'іm koronarnim sindromom bez pod'-ema segmenta ST pri lechenii antagonistom glikoproteiov ІІ''/IIIa zpifibatidom. Kardiologija. 2007;6:4-9.
Serik SA. Immunnovospalitel'naja aktivnost' pri ishemicheskoj bolezni serdca. Ukraїns'kij kardіologіchnij zhurnal. 2002;1:40-45.
Polivoda SN, Cherepok AA. Faktor Villebranda kak marker jendotelial'noj disfunkcii u pacientov s zabolevanijami serdechno-sosudistoj sistemy. Ukraїns'kij revmatologіchnij zhurnal. 2000;1:13-18.
Lutaj MI. Ateroskleroz: sovremenn'їj vigljad na patogenez. Ukraїns'kij kardіologіchnij zhurnal. 2004;1:22-34.
Lutaj MI, Golikova IP, Dejak SI. Vzaimosvjaz' faktora Villebranda s sosudistodvigatel'noj funkciej zndotelija u bol'n'їh s raznoj stepen'ju vyrazhennosti ateroskleroza venechn'їh arterіj. Ukraїns'kij kardіologіchnij zhurnal. 2003;6:13- 17.
Voznjuk LA, Pіvtorak KV, Semenenko SІ. Faktor Vіllebranda jak kriterіj zapalennja і disfunkcії endotelіju u hvorih na іshemіchnu hvorobu sercja. Vіsnik problem bіologії і medicini. 2012;1;2(92):39-42.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 128
Number of citations: 0